Forskning ved Københavns Universitet - Københavns Universitet


SarCNU-induced G2/M arrest in hepatoma cells is mediated by a p53-independent phosphorylation of cdc-2 at Tyr15

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Huynh Hung
  • Chow Kad Hoe Pierce
  • Soo Khee Chee
  • Panasci Lawrence
  • Nguyen Thanh Hung
  • Thanh Hung Nguyen

Hepatocellular carcinoma (HCC) is a major health problem in the Asia-Pacific region, with high incidence and mortality rate. There is currently no effective treatment for inoperable cases that represent the vast majority of patients. In the present study, we report that in vitro treatment of primary hepatoma, HepG2 (wild-type p53), PLC/PRF/5 (p53-mutant), and Hep3B (p53-deleted) cells with 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) resulted in upregulation of p53, p21(Cip1/Waf1), phosphorylated cdc-2 at Tyr15 in wild-type p53 cells and phosphorylation of cdc-2 at Tyr15 in p53-mutant or p53-deleted hepatoma cells. This was accompanied by the reduction in cdc-2 kinase activity and G(2)/M cell cycle arrest. These findings indicate that SarCNU-induced G(2)/M growth arrest in hepatoma cells by a p53-independent phosphorylation of cdc-2. Our data suggest the potential use of SarCNU in treatment of HCC.

TidsskriftJournal of Cellular Physiology
Udgave nummer3
Sider (fra-til)785-91
Antal sider7
StatusUdgivet - sep. 2005
Eksternt udgivetJa

ID: 120744637